HHS Secretary-nominee Xavier Becerra defended his role in pushing for FDA to loosen in-person prescribing requirements for the abortion pill mifepristone, telling members of the Senate health committee Tuesday (Feb. 23) he thinks women should be able access the drug through telemedicine during the pandemic so that they don’t have to get it in-person at a clinic, as that puts them at risk of exposure to COVID-19. Becerra said telehealth has been essential to increasing health care access during the...